Schmithorst, V.J.; Adams, P.S.; Badaly, D.; Lee, V.K.; Wallace, J.; Beluk, N.; Votava-Smith, J.K.; Weinberg, J.G.; Beers, S.R.; Detterich, J.;
et al. Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease. Metabolites 2022, 12, 882.
https://doi.org/10.3390/metabo12090882
AMA Style
Schmithorst VJ, Adams PS, Badaly D, Lee VK, Wallace J, Beluk N, Votava-Smith JK, Weinberg JG, Beers SR, Detterich J,
et al. Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease. Metabolites. 2022; 12(9):882.
https://doi.org/10.3390/metabo12090882
Chicago/Turabian Style
Schmithorst, Vanessa J., Phillip S. Adams, Daryaneh Badaly, Vincent K. Lee, Julia Wallace, Nancy Beluk, Jodie K. Votava-Smith, Jacqueline G. Weinberg, Sue R. Beers, Jon Detterich,
and et al. 2022. "Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease" Metabolites 12, no. 9: 882.
https://doi.org/10.3390/metabo12090882
APA Style
Schmithorst, V. J., Adams, P. S., Badaly, D., Lee, V. K., Wallace, J., Beluk, N., Votava-Smith, J. K., Weinberg, J. G., Beers, S. R., Detterich, J., Wood, J. C., Lo, C. W., & Panigrahy, A.
(2022). Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease. Metabolites, 12(9), 882.
https://doi.org/10.3390/metabo12090882